Published in Diabetes on September 28, 2010
Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science (2013) 8.81
Functional interactions between the gut microbiota and host metabolism. Nature (2012) 7.91
Richness of human gut microbiome correlates with metabolic markers. Nature (2013) 6.93
Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature (2013) 6.07
Conserved shifts in the gut microbiota due to gastric bypass reduce host weight and adiposity. Sci Transl Med (2013) 4.15
Metabolic surgery profoundly influences gut microbial-host metabolic cross-talk. Gut (2011) 3.42
FXR is a molecular target for the effects of vertical sleeve gastrectomy. Nature (2014) 3.34
Insight into the prebiotic concept: lessons from an exploratory, double blind intervention study with inulin-type fructans in obese women. Gut (2012) 3.09
The microbiome in inflammatory bowel disease: current status and the future ahead. Gastroenterology (2014) 2.73
Roux-en-Y Gastric Bypass and Vertical Banded Gastroplasty Induce Long-Term Changes on the Human Gut Microbiome Contributing to Fat Mass Regulation. Cell Metab (2015) 2.65
Targeting gut microbiota in obesity: effects of prebiotics and probiotics. Nat Rev Endocrinol (2011) 2.44
Immunological complications of obesity. Nat Immunol (2012) 2.09
Involvement of gut microbiota in the development of low-grade inflammation and type 2 diabetes associated with obesity. Gut Microbes (2012) 1.83
Do interactions between gut ecology and environmental chemicals contribute to obesity and diabetes? Environ Health Perspect (2011) 1.80
Adaptive immunity in obesity and insulin resistance. Nat Rev Endocrinol (2012) 1.70
The gut microbiome, kidney disease, and targeted interventions. J Am Soc Nephrol (2013) 1.67
Assessing the human gut microbiota in metabolic diseases. Diabetes (2013) 1.64
The gut microbiota and obesity: from correlation to causality. Nat Rev Microbiol (2013) 1.59
Bile acid signaling in metabolic disease and drug therapy. Pharmacol Rev (2014) 1.58
Bile diversion to the distal small intestine has comparable metabolic benefits to bariatric surgery. Nat Commun (2015) 1.57
Meta-analyses of human gut microbes associated with obesity and IBD. FEBS Lett (2014) 1.57
Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease. J Clin Invest (2014) 1.55
The gut microbiota and its relationship to diet and obesity: new insights. Gut Microbes (2012) 1.52
Human gut microbiota changes reveal the progression of glucose intolerance. PLoS One (2013) 1.51
Bacteroides uniformis CECT 7771 ameliorates metabolic and immunological dysfunction in mice with high-fat-diet induced obesity. PLoS One (2012) 1.47
Gut feelings about diabetes. Endocrinol Nutr (2012) 1.46
Retracted Obesity as a consequence of gut bacteria and diet interactions. ISRN Obes (2014) 1.42
Prebiotic fibres dose-dependently increase satiety hormones and alter Bacteroidetes and Firmicutes in lean and obese JCR:LA-cp rats. Br J Nutr (2011) 1.36
Impact of the gut microbiota on the development of obesity and type 2 diabetes mellitus. Front Microbiol (2014) 1.35
Effects of bariatric surgery on glucose homeostasis and type 2 diabetes. Gastroenterology (2012) 1.33
Gut microbiota and diabetes: from pathogenesis to therapeutic perspective. Acta Diabetol (2011) 1.30
A gut microbiota-targeted dietary intervention for amelioration of chronic inflammation underlying metabolic syndrome. FEMS Microbiol Ecol (2013) 1.25
Effects of gut microbes on nutrient absorption and energy regulation. Nutr Clin Pract (2012) 1.25
Roux-en-Y gastric bypass normalizes the blunted postprandial bile acid excursion associated with obesity. Int J Obes (Lond) (2013) 1.24
Mechanisms underlying weight loss after bariatric surgery. Nat Rev Gastroenterol Hepatol (2013) 1.21
The human gut microbiome: a review of the effect of obesity and surgically induced weight loss. JAMA Surg (2013) 1.19
Excess body weight and obesity--the link with gastrointestinal and hepatobiliary cancer. Nat Rev Gastroenterol Hepatol (2011) 1.18
Mechanisms of obesity-induced gastrointestinal neoplasia. Gastroenterology (2013) 1.18
Structural modulation of gut microbiota during alleviation of type 2 diabetes with a Chinese herbal formula. ISME J (2014) 1.17
Is the gut microbiota a new factor contributing to obesity and its metabolic disorders? J Obes (2012) 1.16
Modulation of the gut microbiota by nutrients with prebiotic properties: consequences for host health in the context of obesity and metabolic syndrome. Microb Cell Fact (2011) 1.16
Mucosal-associated invariant T cell alterations in obese and type 2 diabetic patients. J Clin Invest (2015) 1.15
Gut microbiota and metabolic syndrome. World J Gastroenterol (2014) 1.14
Of microbes and meals: the health consequences of dietary endotoxemia. Nutr Clin Pract (2012) 1.10
The human gut microbiome and body metabolism: implications for obesity and diabetes. Clin Chem (2013) 1.07
Gut microbiota, probiotics and diabetes. Nutr J (2014) 1.06
Microbial metabolism of dietary components to bioactive metabolites: opportunities for new therapeutic interventions. Genome Med (2016) 1.05
Plasma lipopolysaccharide is closely associated with glycemic control and abdominal obesity: evidence from bariatric surgery. Diabetes Care (2013) 1.05
The effect of past antibiotic exposure on diabetes risk. Eur J Endocrinol (2015) 1.05
The importance of the gut microbiota after bariatric surgery. Nat Rev Gastroenterol Hepatol (2012) 1.04
Bile acids as metabolic regulators. Curr Opin Gastroenterol (2015) 1.03
Probiotics, prebiotics, and the host microbiome: the science of translation. Ann N Y Acad Sci (2013) 1.01
The role of microbial amino acid metabolism in host metabolism. Nutrients (2015) 0.99
Hypertrophy dependent doubling of L-cells in Roux-en-Y gastric bypass operated rats. PLoS One (2013) 0.99
The gut microbiome, diet, and links to cardiometabolic and chronic disorders. Nat Rev Nephrol (2015) 0.98
Gut microbiota, microinflammation, metabolic profile, and zonulin concentration in obese and normal weight subjects. Int J Endocrinol (2013) 0.98
Obesity surgery and gut-brain communication. Physiol Behav (2011) 0.97
Neuropsychiatric comorbidity in obesity: role of inflammatory processes. Front Endocrinol (Lausanne) (2014) 0.95
Faecal D/L lactate ratio is a metabolic signature of microbiota imbalance in patients with short bowel syndrome. PLoS One (2013) 0.95
Probiotics, prebiotics, and synbiotics: gut and beyond. Gastroenterol Res Pract (2012) 0.94
The physiology underlying Roux-en-Y gastric bypass: a status report. Am J Physiol Regul Integr Comp Physiol (2014) 0.93
Metabolic endotoxemia with obesity: Is it real and is it relevant? Biochimie (2015) 0.93
Bile-acid-mediated decrease in endoplasmic reticulum stress: a potential contributor to the metabolic benefits of ileal interposition surgery in UCD-T2DM rats. Dis Model Mech (2012) 0.93
Metabolic surgery: action via hormonal milieu changes, changes in bile acids or gut microbiota? A summary of the literature. Best Pract Res Clin Gastroenterol (2014) 0.92
The role of bile acids in reducing the metabolic complications of obesity after bariatric surgery: a systematic review. Int J Obes (Lond) (2015) 0.92
Gut-liver axis, nutrition, and non-alcoholic fatty liver disease. Clin Biochem (2015) 0.91
Effects of bariatric surgery on adipokine-induced inflammation and insulin resistance. Front Endocrinol (Lausanne) (2013) 0.90
Bile acid dysregulation, gut dysbiosis, and gastrointestinal cancer. Exp Biol Med (Maywood) (2014) 0.90
Effects of surgical and dietary weight loss therapy for obesity on gut microbiota composition and nutrient absorption. Biomed Res Int (2015) 0.89
Novel Testing Enhances Irritable Bowel Syndrome Medical Management: The IMMINENT Study. Glob Adv Health Med (2014) 0.89
In vitro characterization of the impact of different substrates on metabolite production, energy extraction and composition of gut microbiota from lean and obese subjects. PLoS One (2014) 0.88
Restoration of euglycemia after duodenal bypass surgery is reliant on central and peripheral inputs in Zucker fa/fa rats. Diabetes (2012) 0.88
Metagenomic insights into tetracycline effects on microbial community and antibiotic resistance of mouse gut. Ecotoxicology (2015) 0.88
Unraveling the environmental and genetic interactions in atherosclerosis: Central role of the gut microbiota. Atherosclerosis (2015) 0.88
Probiotics and Prebiotics: Present Status and Future Perspectives on Metabolic Disorders. Nutrients (2016) 0.87
The Intestinal Microbiota in Metabolic Disease. Nutrients (2016) 0.87
Management of metabolic syndrome through probiotic and prebiotic interventions. Indian J Endocrinol Metab (2012) 0.87
Short-term weight loss attenuates local tissue inflammation and improves insulin sensitivity without affecting adipose inflammation in obese mice. Am J Physiol Endocrinol Metab (2013) 0.87
Mechanistic links between gut microbial community dynamics, microbial functions and metabolic health. World J Gastroenterol (2014) 0.86
Dietary patterns differently associate with inflammation and gut microbiota in overweight and obese subjects. PLoS One (2014) 0.86
Modulation of the gut microbiota by nutrients with prebiotic and probiotic properties. Adv Nutr (2014) 0.86
Systematic analysis of the association between gut flora and obesity through high-throughput sequencing and bioinformatics approaches. Biomed Res Int (2014) 0.86
Temporal changes in bile acid levels and 12α-hydroxylation after Roux-en-Y gastric bypass surgery in type 2 diabetes. Int J Obes (Lond) (2015) 0.86
The intestinal microbiome of fish under starvation. BMC Genomics (2014) 0.86
Mechanism Underlying the Weight Loss and Complications of Roux-en-Y Gastric Bypass. Review. Obes Surg (2016) 0.85
The sum of many parts: potential mechanisms for improvement in glucose homeostasis after bariatric surgery. Curr Diab Rep (2014) 0.85
In vitro fermentation of NUTRIOSE(®) FB06, a wheat dextrin soluble fibre, in a continuous culture human colonic model system. PLoS One (2013) 0.85
Mechanisms responsible for excess weight loss after bariatric surgery. J Diabetes Sci Technol (2011) 0.84
SPRING: an RCT study of probiotics in the prevention of gestational diabetes mellitus in overweight and obese women. BMC Pregnancy Childbirth (2013) 0.83
Roux-en-Y gastric bypass surgery of morbidly obese patients induces swift and persistent changes of the individual gut microbiota. Genome Med (2016) 0.83
Mechanisms behind the immediate effects of Roux-en-Y gastric bypass surgery on type 2 diabetes. Theor Biol Med Model (2013) 0.83
Comparison of the gut microbiota composition between obese and non-obese individuals in a Japanese population, as analyzed by terminal restriction fragment length polymorphism and next-generation sequencing. BMC Gastroenterol (2015) 0.82
In silico identification of bacteriocin gene clusters in the gastrointestinal tract, based on the Human Microbiome Project's reference genome database. BMC Microbiol (2015) 0.82
Microbiome and metabolic disease: revisiting the bacterial phylum Bacteroidetes. J Mol Med (Berl) (2016) 0.82
FGF 19 and Bile Acids Increase Following Roux-en-Y Gastric Bypass but Not After Medical Management in Patients with Type 2 Diabetes. Obes Surg (2016) 0.81
New-found link between microbiota and obesity. World J Gastrointest Pathophysiol (2015) 0.81
Gastrointestinal changes after bariatric surgery. Diabetes Metab (2013) 0.81
Obesity-Associated Alterations in Inflammation, Epigenetics, and Mammary Tumor Growth Persist in Formerly Obese Mice. Cancer Prev Res (Phila) (2016) 0.80
The gut microbiome in cardio-metabolic health. Genome Med (2015) 0.80
Role of Adiposity-Driven Inflammation in Depressive Morbidity. Neuropsychopharmacology (2016) 0.80
A core gut microbiome in obese and lean twins. Nature (2008) 52.30
An obesity-associated gut microbiome with increased capacity for energy harvest. Nature (2006) 44.35
Microbial ecology: human gut microbes associated with obesity. Nature (2006) 36.98
Obesity alters gut microbial ecology. Proc Natl Acad Sci U S A (2005) 33.66
The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci U S A (2004) 26.56
Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science (1993) 25.54
Bariatric surgery: a systematic review and meta-analysis. JAMA (2004) 23.34
Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci U S A (2008) 14.18
Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med (2009) 13.91
Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes (2008) 10.74
Human gut microbiota in obesity and after gastric bypass. Proc Natl Acad Sci U S A (2009) 8.25
Role of leptin in the neuroendocrine response to fasting. Nature (1996) 8.02
Symbiotic gut microbes modulate human metabolic phenotypes. Proc Natl Acad Sci U S A (2008) 6.42
Monocyte chemoattractant protein 1 in obesity and insulin resistance. Proc Natl Acad Sci U S A (2003) 6.06
Towards the human intestinal microbiota phylogenetic core. Environ Microbiol (2009) 5.72
Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia (2007) 5.61
Human colonic microbiota associated with diet, obesity and weight loss. Int J Obes (Lond) (2008) 4.78
Low counts of Faecalibacterium prausnitzii in colitis microbiota. Inflamm Bowel Dis (2009) 4.72
Quantitative real-time PCR for Porphyromonas gingivalis and total bacteria. J Clin Microbiol (2000) 3.03
Effects of Roux-en-Y gastric bypass surgery on fasting and postprandial concentrations of plasma ghrelin, peptide YY, and insulin. J Clin Endocrinol Metab (2004) 3.01
Salsalate improves glycemia and inflammatory parameters in obese young adults. Diabetes Care (2007) 2.92
Regulation of myocardial ketone body metabolism by the gut microbiota during nutrient deprivation. Proc Natl Acad Sci U S A (2009) 2.91
Glucagon-like peptide-1, peptide YY, hunger, and satiety after gastric bypass surgery in morbidly obese subjects. J Clin Endocrinol Metab (2006) 2.78
Energy intake is associated with endotoxemia in apparently healthy men. Am J Clin Nutr (2008) 2.77
The importance of caloric restriction in the early improvements in insulin sensitivity after Roux-en-Y gastric bypass surgery. Diabetes Care (2010) 2.64
Gut microbiota and its possible relationship with obesity. Mayo Clin Proc (2008) 2.63
Interplay between weight loss and gut microbiota composition in overweight adolescents. Obesity (Silver Spring) (2009) 2.36
Dietary underreporting by obese individuals--is it specific or non-specific? BMJ (1995) 2.34
Prospective study of gut hormone and metabolic changes after adjustable gastric banding and Roux-en-Y gastric bypass. Int J Obes (Lond) (2009) 2.28
Shifts in clostridia, bacteroides and immunoglobulin-coating fecal bacteria associated with weight loss in obese adolescents. Int J Obes (Lond) (2008) 2.09
Comparative assessment of human and farm animal faecal microbiota using real-time quantitative PCR. FEMS Microbiol Ecol (2009) 1.89
The role of pH in determining the species composition of the human colonic microbiota. Environ Microbiol (2009) 1.87
Systemic low-grade inflammation is related to both circulating and adipose tissue TNFalpha, leptin and IL-6 levels in obese women. Int J Obes Relat Metab Disord (2004) 1.76
Gut microflora as a target for energy and metabolic homeostasis. Curr Opin Clin Nutr Metab Care (2007) 1.75
Statins as anti-inflammatory agents. Trends Pharmacol Sci (2002) 1.55
Obesity, metabolic syndrome, and type 2 diabetes: inflammatory basis of glucose metabolic disorders. Nutr Rev (2007) 1.50
Effect of fasting, refeeding, and dietary fat restriction on plasma leptin levels. J Clin Endocrinol Metab (1997) 1.46
Effect of weight loss on insulin sensitivity and intramuscular long-chain fatty acyl-CoAs in morbidly obese subjects. Diabetes (2002) 1.40
Physiology: obesity and gut flora. Nature (2006) 1.32
Secretory granules of endocrine and chief cells of human stomach mucosa contain leptin. Int J Obes Relat Metab Disord (2000) 1.26
Effects of weight loss from a very-low-carbohydrate diet on endothelial function and markers of cardiovascular disease risk in subjects with abdominal obesity. Am J Clin Nutr (2008) 1.25
Long-term outcome of bariatric surgery: an interim analysis. Mayo Clin Proc (2006) 1.10
Regulation of inflammation-related genes in human adipose tissue. J Intern Med (2007) 1.10
Medicine. Bypassing medicine to treat diabetes. Science (2008) 1.00
Relationship between single nucleotide polymorphisms in leptin, IL6 and adiponectin genes and their circulating product in morbidly obese subjects before and after gastric banding surgery. Obes Surg (2005) 0.91
Effect of gastric bypass on gastric secretion. 1977. Surg Obes Relat Dis (2006) 0.87
The relationship between levels of alpha1-acid glycoprotein and metabolic parameters of diabetes mellitus. Diabetes Nutr Metab (2004) 0.85
Adipose tissue gene expression in patients with a loss of function mutation in the leptin receptor. Int J Obes Relat Metab Disord (2002) 0.81
A human gut microbial gene catalogue established by metagenomic sequencing. Nature (2010) 43.63
Enterotypes of the human gut microbiome. Nature (2011) 24.36
Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci U S A (2008) 14.18
Richness of human gut microbiome correlates with metabolic markers. Nature (2013) 6.93
Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss. Diabetes (2005) 5.68
Power and limitations of the chloroplast trnL (UAA) intron for plant DNA barcoding. Nucleic Acids Res (2006) 5.31
The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide. Science (2013) 4.60
Variants of ENPP1 are associated with childhood and adult obesity and increase the risk of glucose intolerance and type 2 diabetes. Nat Genet (2005) 4.44
Genomic variation landscape of the human gut microbiome. Nature (2012) 4.38
Genetic deficiency and pharmacological stabilization of mast cells reduce diet-induced obesity and diabetes in mice. Nat Med (2009) 3.97
Differences in fecal microbiota in different European study populations in relation to age, gender, and country: a cross-sectional study. Appl Environ Microbiol (2006) 3.82
Dietary intervention impact on gut microbial gene richness. Nature (2013) 3.56
Downward trends in the prevalence of childhood overweight in the setting of 12-year school- and community-based programmes. Public Health Nutr (2008) 3.53
Krüppel-like factor 4 regulates macrophage polarization. J Clin Invest (2011) 3.08
Increased infiltration of macrophages in omental adipose tissue is associated with marked hepatic lesions in morbid human obesity. Diabetes (2006) 3.06
Colonic microbiota signatures across five northern European countries. Appl Environ Microbiol (2005) 2.98
Biodiversity of the mucosa-associated microbiota is stable along the distal digestive tract in healthy individuals and patients with IBD. Inflamm Bowel Dis (2005) 2.93
Effects of bariatric surgery on cardiac ectopic fat: lesser decrease in epicardial fat compared to visceral fat loss and no change in myocardial triglyceride content. J Am Coll Cardiol (2012) 2.88
Microbial dysbiosis in colorectal cancer (CRC) patients. PLoS One (2011) 2.84
Weight loss regulates inflammation-related genes in white adipose tissue of obese subjects. FASEB J (2004) 2.82
Single-nucleotide polymorphism haplotypes in the both proximal promoter and exon 3 of the APM1 gene modulate adipocyte-secreted adiponectin hormone levels and contribute to the genetic risk for type 2 diabetes in French Caucasians. Hum Mol Genet (2002) 2.72
Twin study indicates loss of interaction between microbiota and mucosa of patients with ulcerative colitis. Gastroenterology (2011) 2.52
Gut microbiota after gastric bypass in human obesity: increased richness and associations of bacterial genera with adipose tissue genes. Am J Clin Nutr (2013) 2.52
Metagenomic species profiling using universal phylogenetic marker genes. Nat Methods (2013) 2.51
Fibrosis in human adipose tissue: composition, distribution, and link with lipid metabolism and fat mass loss. Diabetes (2010) 2.46
Specificities of the fecal microbiota in inflammatory bowel disease. Inflamm Bowel Dis (2006) 2.45
Increased adipose tissue oxygen tension in obese compared with lean men is accompanied by insulin resistance, impaired adipose tissue capillarization, and inflammation. Circulation (2011) 2.41
Adipose tissue transcriptomic signature highlights the pathological relevance of extracellular matrix in human obesity. Genome Biol (2008) 2.22
Defective leptin/leptin receptor signaling improves regulatory T cell immune response and protects mice from atherosclerosis. Arterioscler Thromb Vasc Biol (2007) 2.21
Molecular inventory of faecal microflora in patients with Crohn's disease. FEMS Microbiol Ecol (2004) 2.21
Dietary factors and low-grade inflammation in relation to overweight and obesity. Br J Nutr (2011) 2.16
Human adipose tissue macrophages: m1 and m2 cell surface markers in subcutaneous and omental depots and after weight loss. J Clin Endocrinol Metab (2009) 2.14
Intestinal microbiota of 6-week-old infants across Europe: geographic influence beyond delivery mode, breast-feeding, and antibiotics. J Pediatr Gastroenterol Nutr (2010) 2.13
Clinical features and outcomes in 348 patients with polyarteritis nodosa: a systematic retrospective study of patients diagnosed between 1963 and 2005 and entered into the French Vasculitis Study Group Database. Arthritis Rheum (2010) 2.11
Intima-media thickness in severe obesity: links with BMI and metabolic status but not with systemic or adipose tissue inflammation. Diabetes Care (2013) 2.10
Fibrosis and adipose tissue dysfunction. Cell Metab (2013) 2.07
Bacterial imprinting of the neonatal immune system: lessons from maternal cells? Pediatrics (2007) 2.07
Elevated plasma ghrelin levels in Prader Willi syndrome. Nat Med (2002) 1.97
Chronic intermittent hypoxia is a major trigger for non-alcoholic fatty liver disease in morbid obese. J Hepatol (2011) 1.94
Comparative assessment of human and farm animal faecal microbiota using real-time quantitative PCR. FEMS Microbiol Ecol (2009) 1.89
Design and validation of 16S rRNA probes to enumerate members of the Clostridium leptum subgroup in human faecal microbiota. Environ Microbiol (2005) 1.89
Melanocortin 4 receptor mutations in a large cohort of severely obese adults: prevalence, functional classification, genotype-phenotype relationship, and lack of association with binge eating. J Clin Endocrinol Metab (2006) 1.84
Toxicological function of adipose tissue: focus on persistent organic pollutants. Environ Health Perspect (2012) 1.82
Inflammatory pathway genes belong to major targets of persistent organic pollutants in adipose cells. Environ Health Perspect (2012) 1.78
Potential contribution of adipose tissue to elevated serum cystatin C in human obesity. Obesity (Silver Spring) (2009) 1.77
Treatment for 2 mo with n 3 polyunsaturated fatty acids reduces adiposity and some atherogenic factors but does not improve insulin sensitivity in women with type 2 diabetes: a randomized controlled study. Am J Clin Nutr (2007) 1.71
Genomic analysis of smooth tubercle bacilli provides insights into ancestry and pathoadaptation of Mycobacterium tuberculosis. Nat Genet (2013) 1.67
Functional metagenomics to mine the human gut microbiome for dietary fiber catabolic enzymes. Genome Res (2010) 1.64
Unraveling the genetics of human obesity. PLoS Genet (2006) 1.63
Fluorescent hybridisation combined with flow cytometry and hybridisation of total RNA to analyse the composition of microbial communities in human faeces using 16S rRNA probes. FEMS Microbiol Ecol (2003) 1.63
Enumeration of Bacteroides species in human faeces by fluorescent in situ hybridisation combined with flow cytometry using 16S rRNA probes. Syst Appl Microbiol (2003) 1.61
Management of obesity in adults: European clinical practice guidelines. Obes Facts (2008) 1.59
Role of transcription factor KLF11 and its diabetes-associated gene variants in pancreatic beta cell function. Proc Natl Acad Sci U S A (2005) 1.59
Defining macrophage phenotype and function in adipose tissue. Trends Immunol (2011) 1.57
Factors related to lipodystrophy and metabolic alterations in patients with human immunodeficiency virus infection receiving highly active antiretroviral therapy. Clin Infect Dis (2002) 1.57
Overweight and obesity: knowledge, attitudes, and practices of general practitioners in france. Obes Res (2005) 1.55
Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients. Hepatology (2012) 1.52
A marker of endotoxemia is associated with obesity and related metabolic disorders in apparently healthy Chinese. Diabetes Care (2010) 1.52
Clustering biological annotations and gene expression data to identify putatively co-regulated biological processes. J Bioinform Comput Biol (2006) 1.50
In vivo epinephrine-mediated regulation of gene expression in human skeletal muscle. J Clin Endocrinol Metab (2004) 1.49
Growth hormone therapy for children and adolescents with Prader-Willi syndrome is associated with improved body composition and metabolic status in adulthood. J Clin Endocrinol Metab (2013) 1.47
Cathepsin s promotes human preadipocyte differentiation: possible involvement of fibronectin degradation. Endocrinology (2006) 1.45
Chemerin correlates with markers for fatty liver in morbidly obese patients and strongly decreases after weight loss induced by bariatric surgery. J Clin Endocrinol Metab (2010) 1.44
Determinants of the human infant intestinal microbiota after the introduction of first complementary foods in infant samples from five European centres. Microbiology (2011) 1.44